首页> 外文期刊>European journal of human genetics: EJHG >Search for cis-acting factors and maternal effect variants in Silver-Russell patients with ICR1 hypomethylation and their mothers.
【24h】

Search for cis-acting factors and maternal effect variants in Silver-Russell patients with ICR1 hypomethylation and their mothers.

机译:在Silver-Russell患者和母亲中寻找银罗素患者的CIS-Actute因子和母体效果变种。

获取原文
获取原文并翻译 | 示例
           

摘要

Silver-Russell syndrome is an imprinting disorder characterized by severe intrauterine and postnatal growth retardation. The majority of patients show loss of methylation (LOM) of the H19/IGF2 IG-DMR (ICR1) in 11p15.5. In ~10% of these patients aberrant methylation of additional imprinted loci on other chromosomes than 11 can be observed (multilocus imprinting defect - MLID). Recently, genomic variations in the ICR1 have been associated with disturbed methylation of the ICR1. In addition, variants in factors contributing to the life cycle of imprinting are discussed to cause aberrant imprinting, including MLID. These variants can either be identified in the patients with imprinting disorders themselves or in their mothers. We performed comprehensive studies to elucidate the role of both cis-acting variants in 11p15.5 as well as of maternal effect variants in the etiology of ICR1 LOM. Whereas copy number analysis and next generation sequencing in the ICR1 did not provide any evidence for a variant, search for maternal effect variants in 21 mothers of patients with ICR1 LOM identified two carriers of NLRP5 variants. By considering our results as well as those from the literature, we conclude that the causes for epimutations are heterogeneous. MLID might be regarded as an own etiological subgroup, associated with maternal effect variants in NLRP and functionally related genes. In addition, these variants might also contribute to LOM of single imprinted loci. Furthermore, genomic variants in the patients themselves might result in aberrant methylation patterns and need further investigation.
机译:银罗素综合征是一种印记障碍,其特征是严重的宫内和产后生长迟缓。大多数患者在11P15.5中显示出H19 / IGF2 IG-DMR(ICR1)的甲基化(LOM)的丧失。在〜10%的这些患者中,可以观察到在其他染色体上的另外的印迹基因座的异常甲基化(多点印记缺损 - 微米)。最近,ICR1的基因组变化已经与ICR1的干扰甲基化相关。此外,讨论了导致印迹生命周期的因素的变体,以导致异常的印记,包括MlID。这些变体可以在患者中鉴定在印记障碍本身或母亲中。我们进行了全面的研究,以阐明CIS作用变体在11P15.5以及ICR1 LOM的病因中的母体效果变体中的作用。虽然ICR1中的拷贝数分析和下一代测序没有提供了一种变体的任何证据,搜索ICR1 LOM患者21名母亲的母体效果变体鉴定了两种NLRP5变体的载体。通过考虑我们的结果以及文献中的结果,我们得出结论,缩影的原因是异构的。 MlID可能被视为自己的病因亚组,与NLRP和功能相关基因中的母体效应变体相关联。此外,这些变体也可能有助于单个印迹基因座的LOM。此外,患者本身的基因组变体可能导致异常的甲基化模式,并需要进一步调查。

著录项

  • 来源
  • 作者单位

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

    Institute of Human Genetics Medical Faculty RWTH Aachen University Aachen Germany;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医学遗传学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号